TRIUMPH-3 confirmed (July 23, 2026): Obesity + established cardiovascular disease, 1,949 patients, 22.6% weight loss, with MACE data not statistically significant (neither benefit nor harm confirmed)
Expect aggressive FDA enforcement against pharmacies that continue large-scale compounding post-shortage without documented patient-specific justifications
A detailed, honest look at the evidence, risks, and what we still don't know about combining them
Sphingosine 1-phosphate (S1P)/S1P receptor signaling and mechanotransduction: implications for intrinsic tissue repair/regeneration
Mistake 5: Reusing syringes Each syringe is designed for single use
254 -catenin degradation via the UPS occurs through either the APC-dependent p53/Siah1 pathway or the APC-independent retinoid X receptor (RXR) pathway